MARY DIAZ-GARCIA: Open Payments
NPI 1083012728 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 53 payments from 18 companies in 2025. Trend: 2023 $940 · 2024 $619 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $193 |
| Madrigal Pharmaceuticals | 19 | $179 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Phathom Pharmaceuticals, Inc. | 6 | $94 |
| Lilly USA, LLC | 5 | $92 |
| Corcept Therapeutics | 3 | $56 |
| Janssen Biotech, Inc. | 2 | $36 |
| BETA BIONICS, INC. | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: REZDIFFRA, Wegovy, AREXVY, VOQUEZNA, Korlym, MOUNJARO, TREMFYA, Ozempic.
Industry payments across NJ — which companies pay providers there.
